- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Sectra and Voxar cut agreement
Scottish software developer Voxar has agreed to supply advanced 3D display and rendering tools from its Plug n View 3D software for use in a radiology workstation developed by Sectra. The 3D software will be integrated into the workstation, providing
Scottish software developer Voxar has agreed to supply advanced 3D display and rendering tools from its Plug n View 3D software for use in a radiology workstation developed by Sectra. The 3D software will be integrated into the workstation, providing users one-click access. The agreement promises to increase Voxar's availability in European and global markets. The Swedish medical technology and IT company has more than 200 PACS installations world.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Researchers Show Higher Breast Cancer Upstaging Rate with 18F-FAPI PET/CT
September 9th 2024The imaging agent 18F-FAPI PET/CT demonstrated greater than a 45 percent higher sensitivity rate in comparison to 18F-FDG PET/CT for the detection of axillary and extraaxillary regional lymph node metastases, according to a lesion-based analysis from a recent study.
